MilliporeSigma Gene Therapy Capabilities

You’ve created a gene therapy with the possibility to help patients. But the development and manufacturing of your gene therapy, how it’s developed, produced and approved, are still being outlined. No process template exists. You have to design one as you go, despite the uncertainty and unique challenges. We’re here to help. With 30+ years of gene therapy experience, we bring expertise in viral vector manufacturing and testing as well as a global organization to integrate process development, scale-up, safety testing and regulatory guidance to meet your process needs.

Our products and services for AAV, Lentivirus and other viral vectors provide solutions to your most challenging pain points around process development, speed, manufacturing and regulatory guidelines. We are ready for you to draw on our experience to help bring your gene therapy to life.